BIOCRYST PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Biocryst Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $7.69M.
  • Biocryst Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$40.7M, a 62.1% increase year-over-year.
  • Biocryst Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$104M, a 30.1% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$148M, a 16.5% increase from 2021.
  • Biocryst Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$178M, a 1.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$40.7M $7.69M +$19.6M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$60.3M $8.76M +$29.5M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$89.8M -$14.5M +$13.9M +49% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$104M -$42.7M +$3.64M +7.86% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$107M -$11.9M +$5.52M +31.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$113M -$20.7M +$14M +40.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$127M -$28.4M +$21.5M +43.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$148M -$46.3M +$5.87M +11.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$154M -$17.4M +$27.1M +60.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$181M -$34.7M -$5.14M -17.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$176M -$50M +$1.42M +2.76% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$178M -$52.2M +$228K +0.44% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$178M -$44.6M -$1.72M -4.01% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$176M -$29.6M +$8.93M +23.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$185M -$51.4M -$10.4M -25.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$175M -$52.4M -$52.3M -47978% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$122M -$42.9M -$7.77M -22.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$115M -$38.5M -$3.59M -10.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$111M -$41M -$11.6M -39.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$99.5M -$109K +$25.2M +99.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$125M -$35.1M -$6.61M -23.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$118M -$34.9M -$16.7M -91.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$101M -$29.3M -$7.12M -32% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$94.2M -$25.3M -$7.4M -41.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$86.8M -$28.5M -$15.1M -113% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$71.7M -$18.3M -$2.74M -17.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$68.9M -$22.2M -$11.5M -108% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$57.4M -$17.9M -$9.67M -118% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-13
Q3 2017 -$47.7M -$13.3M -$4.11M -44.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$43.6M -$15.5M -$3.39M -27.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$40.2M -$10.7M +$8.36M +43.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$48.6M -$8.19M +$9.01M +52.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 -$57.6M -$9.24M +$3.92M +29.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$61.5M -$12.1M -$17.5M -327% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$44.1M -$19M -$4.62M -32% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$39.4M -$17.2M -$2.04M -13.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$37.4M -$13.2M -$1.55M -13.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$35.9M $5.34M +$17M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$52.8M -$14.4M -$7.04M -95.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$45.8M -$15.2M -$8.82M -139% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$36.9M -$11.6M -$4.69M -67.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$32.3M -$11.6M +$523K +4.31% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$32.8M -$7.39M -$2.07M -38.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$30.7M -$6.33M +$4.36M +40.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$35.1M -$6.93M +$1.09M +13.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$36.2M -$12.1M -$1.97M -19.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$34.2M -$5.32M -$315K -6.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$33.9M -$10.7M +$345K +3.13% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$34.2M -$8.02M +$4.79M +37.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$39M -$10.2M +$4.07M +28.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$43.1M -$5M +$6.5M +56.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$49.6M -$11M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-10
Q3 2011 -$12.8M -$1.82M -16.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$14.2M -$3.91M -37.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$11.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q3 2010 -$11M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 -$10.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.